It has been reported that GP was capable to protect mice and cells from nonalcoholic fatty liver disease-induced oxidative stress and inflammation, which were mostly depend on up-regulating the protein expression of Nrf2/HO-1 and AMPK signalling pathways (Shen et al., 2020). This evidence concerns the gene HMOX1 and metabolic dysfunction-associated steatotic liver disease.